News
Structure Therapeutics (GPCR) stock and Metsera (MTSR) stock soar as Eli Lilly (LLY) reports promising Phase 3 results for ...
Viking (VKTX) stock, Structure (GPCR) stock and others surge after Pfizer’s obesity drug setback. Read more here.
For the first time in months, Dalal Street is witnessing a complete pause in the IPO action with no mainboard listings, no SME buzz, just silence. This will be the first IPO-free week since ...
Zhipu AI, a Beijing-based artificial intelligence (AI) unicorn born out of China’s prestigious Tsinghua University, has filed pre-initial public offering (IPO) documents with China’s ...
The U.S. IPO market, which made a strong comeback last year from a slew of high-profile listings, has been rattled by market volatility stemming from tariff-related uncertainty, with companies ...
Saudi Arabia is set to see a slew of companies test investor appetite for initial public offerings over the coming weeks, a sign that the kingdom’s deal pipeline is holding up so far despite the ...
As per Inc42 data, 20 startups are in various stages of undertaking their IPO preparations at the outset of 2025 Key factors that are likely to contribute to the public listing mania in 2025 are ...
Chinese household robot brand Narwal Robotics announced on Monday it had secured US$100 million in a new funding round led by Tencent Holdings and the state-backed Beijing Robot Industry ...
Metsera Inc. also stands to benefit, as while its oral GLP-1 is a bit behind, initial data is expected in the fourth quarter of this year. Structure Therapeutics' stock (GPCR) shot up 12.4% in ...
BENGALURU, April 17 (Reuters) - The chairman of India's market regulator said on Thursday it was working to resolve issues delaying the National Stock Exchange's (NSE) long-awaited listing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results